Step 1 topics → Neurology and Special Senses → Parkinson Disease

Parkinson Disease

USMLE Step 1 trap: Confuses the protein composition of Lewy bodies (alpha-synuclein) with tau-containing inclusions. Lewy bodies are intracytoplasmic inclusions composed of alpha-synuclein and ubiquitin, found in surviving dopaminergic neurons of the substantia nigra pars compacta.

Parkinson disease is one of the most tested neurology topics on USMLE Step 1, and it gets tested from multiple angles: pure recall of the pathology, clinical presentation recognition, and passage-based questions that ask you to distinguish it from look-alike syndromes. At its core, Parkinson disease is a movement disorder caused by loss of dopaminergic neurons in the substantia nigra pars compacta, with the histologic hallmark being Lewy bodies — intracytoplasmic inclusions made of alpha-synuclein and ubiquitin found in surviving neurons. The gross correlate is loss of neuromelanin pigmentation in the substantia nigra, which you should be able to recognize in a photo or described in a vignette.

The exam loves the TRAP mnemonic (Tremor at rest, Rigidity, Akinesia/bradykinesia, Postural instability) as the clinical anchor, but it also tests associated features like masked facies, micrographia, shuffling/festinating gait, and the pill-rolling quality of the tremor. Students get tripped up when a vignette describes dementia alongside parkinsonism — you need to know when that points to Lewy body dementia versus idiopathic PD, and what that means for treatment. MPTP exposure as a toxic model of PD (destroys dopaminergic neurons selectively) also shows up, especially in mechanism-style questions.

The trickiest part of this topic on USMLE Step 1 is the differential: Parkinson-plus syndromes like PSP, MSA, and Lewy body dementia share some features with idiopathic PD but have distinguishing findings that the exam specifically targets. Knowing which features belong to which syndrome — not just that they exist — is what separates a high scorer from someone who just memorized the buzzwords.

From real student decks
89%have cards covering this topic
84%have mature cards
2median lapses in 14 days

Well-covered in most decks — the challenge is retention, not exposure.

Common misconceptions

Common mistake
Wrong: Lewy bodies are composed of tau protein.
Right: Lewy bodies are intracytoplasmic inclusions composed of alpha-synuclein and ubiquitin, found in surviving dopaminergic neurons of the substantia nigra pars compacta.
Lewy bodies are made of alpha-synuclein and ubiquitin — not tau. Tau is the protein in neurofibrillary tangles (Alzheimer disease, PSP, CTE). The distinction matters because Parkinson disease, Lewy body dementia, and multiple system atrophy are all alpha-synucleinopathies, while Alzheimer and PSP are tauopathies. When a question asks about the protein in Lewy bodies, alpha-synuclein is always the right answer.
Common mistake
Wrong: Parkinson rigidity is spastic (velocity-dependent) like upper motor neuron lesions.
Right: Parkinson rigidity is cogwheel or lead-pipe (velocity-independent), reflecting basal ganglia dysfunction rather than UMN pathology.
Cogwheel rigidity is velocity-independent — it feels the same whether you move the limb fast or slow, presenting as a ratchet-like catch throughout the range of motion. Spasticity from UMN lesions is velocity-dependent: resistance increases as you move faster (the 'clasp-knife' phenomenon). These are fundamentally different mechanisms — basal ganglia dysfunction versus corticospinal tract damage — so the exam will use the clinical description to distinguish them.
Common mistake
Wrong: Antipsychotics are safe to use for hallucinations in Parkinson disease and Lewy body dementia.
Right: Typical antipsychotics and many atypicals are contraindicated in Lewy body dementia and Parkinson disease because dopamine blockade causes severe neuroleptic sensitivity reactions.
Dopamine blockade in the context of Lewy body pathology causes severe, sometimes fatal neuroleptic sensitivity reactions — dramatic worsening of parkinsonism, confusion, and autonomic instability. This is why typical antipsychotics and most atypicals are contraindicated in DLB and PD. If you see a vignette about treating hallucinations in a Parkinson or DLB patient, the answer is quetiapine or clozapine (the low-D2 blocking atypicals), not haloperidol.
Common mistake
Wrong: Vertical gaze palsy is a feature of idiopathic Parkinson disease.
Right: Vertical (downward) gaze palsy is the hallmark of Progressive Supranuclear Palsy (PSP), a Parkinson-plus syndrome, not idiopathic Parkinson disease.
Vertical gaze palsy — specifically downward gaze palsy — is the cardinal distinguishing feature of Progressive Supranuclear Palsy (PSP), not idiopathic Parkinson disease. PD has no gaze palsy. PSP also has more axial than appendicular rigidity, early postural instability with falls, and tau pathology. When a vignette mentions a Parkinson-like patient who keeps falling backward or can't look down, that's your signal to choose PSP over idiopathic PD.
Free Deck audit

See if your Anki deck covers this topic.

Upload your deck →
Guided session

Stuck on this? An AI tutor that probes your understanding.

Start a session →

What the exam tests

  1. Identify the specific brain region affected in Parkinson disease (substantia nigra pars compacta) and recognize the histologic hallmark (Lewy bodies made of alpha-synuclein and ubiquitin, not tau).
  2. Apply the TRAP mnemonic to a clinical vignette and recognize associated signs like pill-rolling tremor, cogwheel rigidity, masked facies, shuffling/festinating gait, and micrographia.
  3. Distinguish idiopathic Parkinson disease from Parkinson-plus syndromes (PSP, MSA, corticobasal degeneration) and Lewy body dementia based on differentiating features — especially vertical gaze palsy in PSP and the timing of dementia in DLB.

Can you avoid these mistakes?

A 65-year-old man has a resting tremor, cogwheel rigidity, and slow shuffling gait. Brain autopsy would show eosinophilic intracytoplasmic inclusions in surviving neurons of which brain region, and what protein are these inclusions primarily composed of?
A patient with known Parkinson disease develops visual hallucinations. The psychiatry team wants to start haloperidol. Why is this dangerous, and what would be a safer pharmacologic alternative for managing the hallucinations?
A 70-year-old woman presents with parkinsonism, early dementia that preceded motor symptoms by over a year, and vivid visual hallucinations. How does this presentation differ from idiopathic Parkinson disease, and what is the diagnosis?
You are shown two patients: one has increased resistance to passive limb movement that worsens when you move the limb quickly, and the other has a ratchet-like catch regardless of movement speed. Which pattern belongs to Parkinson disease, and what is the other pattern called and what lesion causes it?

Related topics

Basal Ganglia and Motor Loops Neural Tube Formation and Derivatives Neural Crest Derivatives Neural Tube Defects Other Developmental Malformations

See how your Anki deck covers this topic.

Upload your deck for a free audit →